Get started
Author

Ryosuke Yamaga

Observed name: R. Yamaga
ORCID: 0000-0003-3047-3434
Observed ORCID: 0000-0003-3047-3434
OpenAlex ID: A5029873525
Effect of high-dose sulfamethoxazole/trimethoprim and glucocorticoid use on hyperkalemic event: A retrospective observational study
2021 · Toshinori Hirai, Ryosuke Yamaga, et al. · Journal of Infection and Chemotherapy · 11
Low body mass index is a risk factor for hyperkalaemia associated with angiotensin converting enzyme inhibitors and angiotensin II receptor blockers treatments
2018 · T. Hirai, R. Yamaga, et al. · Journal of Clinical Pharmacy and Therapeutics · 9
PDF
Geriatric Patients Are at a High Risk of Hypokalemia Associated with Yokukansan Preparation: A Retrospective Cohort Study
2020 · Toshinori Hirai, Ryosuke Yamaga, et al. · Biological and Pharmaceutical Bulletin · 7
PDF
Acute Kidney Injury Impacts on Hypokalemia Associated with Yokukansan Preparation: A Retrospective Observational Study
2020 · Toshinori Hirai, Ryosuke Yamaga, et al. · Biological and Pharmaceutical Bulletin · 4
PDF
Impact of relative dose intensity on bone marrow suppression induced by S-1: retrospective observational study
2018 · Toshinori Hirai, Ryuichi Ogawa, et al. · Journal of Pharmaceutical Health Care and Sciences · 1
PDF
S-1 induced discoid lupus erythematosus-like lesions and long-term complete response for para-aortic lymph node recurrence of pancreatic ductal adenocarcinoma: a case report
2018 · Ryosuke Yamaga, Koji Tezuka, et al. · Surgical Case Reports · 1
PDF
Body Mass Index-Related Trends in Adverse Events with Enfortumab Vedotin: Analysis of a Pharmacovigilance Database and Medical Records
2026 · Motoki Kei, Shiori Sato, et al. · Biological and Pharmaceutical Bulletin
PDF
Body weight is a risk factor for hyperkalemia related with RAAS blockers treatments
2018 · Toshinori Hirai, Ryosuke Yamaga, et al. · Proceedings for Annual Meeting of The Japanese Pharmacological Society
PDF
Works count: 9
Citation count: 33
H-index: 4
I10-index: 1
Year
Topic
Type